PBLA Financials
Panbela Therapeutics Inc - Financial statements & key metrics
Stock Price
$0.00
Market Cap
$970
EPS
$-34.51
Income Statement Highlights
Most Recent Quarter: 2023-12-31
Revenue
$0.00
Gross Profit
$-25.65M
Operating Income
$-51.29M
Net Income
$-25.26M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$11.80M
Total Liabilities
$16.51M
Shareholders Equity
$-4.71M
Cash & Equivalents
$2.58M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-25.25M
CapEx
$0
Free Cash Flow
$-25.25M
Profitability Metrics
ROE
-8.0%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is PBLA revenue?
PBLA's most recent quarterly revenue was $0.00. Annual revenue can be calculated by summing the four most recent quarters.
Is PBLA profitable?
PBLA reported a loss of $25.26M in the most recent quarter.
What is PBLA market cap?
PBLA has a market capitalization of $970, making it a small-cap stock.
Does PBLA have debt?
View PBLA's balance sheet for debt information.
What is PBLA cash flow?
PBLA's most recent quarterly free cash flow was $-25.25M.